RxDoctor Payments DataLook up a doctor →

Phillip Moye, MD

Emergency Medicine · Goldsboro, NCNPI 1184761868

Payments from drug & device makers

$12,442in general payments, 2019–2025

Across 838 payments — averaging $14.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$1K
  • AbbVie$950
  • Pfizer$894
  • Amgen$691
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$609
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$12,435100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk104$1,355
AstraZeneca61$1,181
AbbVie(2 entities)98$950
Pfizer59$894
Amgen60$691
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC49$609
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)29$467
Merck25$450
Astellas Pharma US Inc19$378
Boehringer Ingelheim22$367
Bayer20$331
E.r. Squibb & Sons, L.L.C.19$297
GSK20$297
Otsuka America Pharmaceutical, Inc.16$293
Lilly USA, LLC15$222
Esperion Therapeutics, Inc.11$203
Takeda Pharmaceuticals U.S.A., Inc.13$200
Aimmune Therapeutics, Inc.9$192
Scilex Pharmaceuticals Inc.11$185
Novartis11$180
Lundbeck LLC9$177
Amarin Pharma, Inc.11$173
Sanofi-aventis U.S. LLC11$145
Biohaven Pharmaceutical Holding Company Ltd.9$145
Sumitomo Pharma America, Inc.8$144
Ardelyx, Inc.9$139
Nestle Healthcare Nutrition Inc.7$135
Jazz Pharmaceuticals Inc.6$102
Abbott6$96
Phathom Pharmaceuticals, Inc.5$94
Upsher-smith Laboratories LLC6$90
Johnson & Johnson6$83
Daiichi Sankyo Inc.5$80
Arbor Pharmaceuticals, Inc.6$80
Ironwood Pharmaceuticals, Inc5$72
Azurity Pharmaceuticals, Inc.4$68
Biohaven Pharmaceuticals, Inc.4$68
Ironshore Pharmaceuticals Inc.4$66
Eisai Inc.5$65
Corcept Therapeutics3$60
Vanda Pharmaceuticals Inc.3$60
Tolmar, Inc.3$55
Kowa Pharmaceuticals America, Inc.4$53
Exact Sciences3$52
Teva Pharmaceuticals USA, Inc.3$48
Seqirus USA Inc2$46
Axsome Therapeutics, Inc.2$41
Vivus LLC2$32
Idorsia Pharmaceuticals US Inc2$27
Sanofi Pasteur Inc.2$26
Medtronic1$22
Philips North America LLC1$18
Scynexis, Inc.1$18
Dexcom, Inc.1$15
Mylan Specialty L.p.1$15
Nabriva Therapeutics, PLC1$14
Globus Medical1$14
Almatica Pharma LLC1$14
Hikma Pharmaceuticals USA1$14
Sunovion Pharmaceuticals Inc.1$13

How this compares

$12,442 in reported general payments places this provider in the 95th percentile of 1,657 emergency medicine providers in North Carolina.

See all emergency medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$124,602
Medicare patients
519
Services billed
1,971

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide106$114,525
EliquisApixaban132$105,069
MounjaroTirzepatide51$57,983
JardianceEmpagliflozin61$51,434
Humalog Kwikpen U-200Insulin Lispro13$37,697
FarxigaDapagliflozin Propanediol24$29,936
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$28,356
RybelsusSemaglutide15$23,784
TrulicityDulaglutide13$19,894
XareltoRivaroxaban23$18,945
Janumet XrSitagliptin Phos/Metformin Hcl15$16,745
QuliptaAtogepant13$15,145
Tresiba Flextouch U-100Insulin Degludec23$11,958
Tresiba Flextouch U-200Insulin Degludec14$10,864
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$9,502

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,355$138,309121 claims
PfizerEliquis$894$105,069132 claims
Lilly USA, LLCMounjaro, Trulicity$222$77,87864 claims
Boehringer IngelheimJardiance$367$51,43461 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,181$39,43837 claims
GSKTrelegy Ellipta$297$28,35631 claims
MerckJanumet Xr, Janumet$450$26,22931 claims
Johnson & JohnsonXarelto$83$18,94523 claims
AbbVieQulipta$950$15,14513 claims
Arbor Pharmaceuticals, Inc.Edarbyclor$80$8,87625 claims
Sumitomo Pharma America, Inc.Gemtesa$144$7,32915 claims
Almatica Pharma LLCSertraline Hcl$14$2,625123 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,657 emergency medicine providers in North Carolina.

Other emergency medicine in Goldsboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →